Global Probiotic Ingredients Market Size Study & Forecast, by Application, Source, Form, End User, and Regional Forecasts 2025-2035

The Global Probiotic Ingredients Market is valued approximately at USD 0.42 billion in 2024 and is anticipated to grow at a robust CAGR of 8.50% over the forecast period 2025–2035. Probiotic ingredients, derived from specific strains of bacteria or yeast, have emerged as a cornerstone of functional nutrition and therapeutic innovation. These microorganisms are introduced intentionally into food systems and pharmaceutical products to restore gut health, enhance immunity, and deliver preventive healthcare. Rising consumer inclination towards digestive wellness, immunity-boosting foods, and personalized nutrition solutions has dramatically elevated the market potential. In parallel, product innovations targeting novel delivery mechanisms such as microencapsulation and synbiotics have carved competitive differentiation for key stakeholders across global markets.

The growing integration of probiotics into functional food and beverage portfolios—especially dairy products, fermented drinks, and supplements—has unlocked remarkable commercial opportunities. Brands have been capitalizing on clean-label trends and health-conscious consumer behavior by introducing probiotics in everyday consumables. Moreover, rising clinical interest in the gut-brain axis and microbiome modulation has stimulated investments in probiotic therapeutics for applications ranging from mental health to dermatology. On the animal nutrition front, probiotics are increasingly replacing antibiotics in livestock feed, enhancing digestive efficiency and immunity in poultry and cattle—particularly relevant in post-antibiotic regulatory landscapes across the EU and North America. Meanwhile, the pharmaceutical industry's increasing exploration of probiotic APIs for conditions such as IBS, urogenital disorders, and antibiotic-associated diarrhea continues to expand the functional scope of this bioactive category.

From a regional standpoint, North America currently commands a prominent share of the global probiotic ingredients market, underpinned by heightened consumer awareness, advanced healthcare infrastructure, and widespread demand for fortified consumables. The U.S., in particular, has witnessed a proliferation of probiotic-infused products and dietary supplements targeted toward adults, children, and aging populations alike. Meanwhile, Asia Pacific is poised to emerge as the fastest-growing region, with China, India, and Japan spearheading growth due to increasing disposable income, a rapidly expanding middle class, and a growing appetite for functional food innovations. Europe, with its rich history of fermented food culture and stringent regulatory oversight from EFSA, remains a mature yet innovation-driven market, with Scandinavian countries setting benchmarks in probiotic R&D.

Major market player included in this report are:
• DuPont de Nemours, Inc.
• Kerry Group plc
• Chr. Hansen Holding A/S
• Lallemand Inc.
• Probi AB
• Archer Daniels Midland Company
• Koninklijke DSM N.V.
• Novozymes A/S
• Yakult Honsha Co., Ltd.
• BioGaia AB
• Danone S.A.
• Ganeden, Inc.
• Morinaga Milk Industry Co., Ltd.
• UAS Laboratories LLC
• Sabinsa Corporation

Global Probiotic Ingredients Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Application:
• Functional Foods & Beverages
• Pharmaceuticals
• Animal Nutrition

By Source:
• Bacteria
• Yeast

By Form:
• Dry
• Liquid

By End User:
• Human
• Animal

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more